Louvain-la-Neuve, Belgium, 11 July 2022 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today that it will publish its consolidated results for the half year 2022 on Wednesday, 31 August 2022 at 7am CEST.

Conference Call Information
Olivier Legrain, Chief Executive Officer, and Soumya Chandramouli, Chief Financial Officer, will host a hybrid event, including a conference call and webcast, conducted in English, to present the half year results, followed by a Q&A session.

The conference call will be held on Wednesday,31 August 2022 at 3pm CEST / 2pm BST / 9am EDT / 6amPDT as a Teams webinar